These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 33413932)
1. Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection. Martin AC; Godier A; Karam N J Am Coll Cardiol; 2021 Jan; 77(1):104. PubMed ID: 33413932 [No Abstract] [Full Text] [Related]
2. Reply: Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection. Choudry FA; Rathod KS; Baumbach A; Mathur A; Jones DA J Am Coll Cardiol; 2021 Jan; 77(1):105-106. PubMed ID: 33413933 [No Abstract] [Full Text] [Related]
3. The Clinical Challenge of ST-Segment Elevation Myocardial Infarction and COVID-19. Kornowski R; Orvin K J Am Coll Cardiol; 2021 Apr; 77(16):2004-2006. PubMed ID: 33888250 [No Abstract] [Full Text] [Related]
4. ST-segment elevation myocardial infarction in times of COVID-19: back to the last century? A call for attention. Gadella A; Sastre MÁ; Maicas C; Rodríguez-Padial L; Arias MÁ Rev Esp Cardiol (Engl Ed); 2020 Jul; 73(7):582-583. PubMed ID: 32381326 [No Abstract] [Full Text] [Related]
5. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Stefanini GG; Montorfano M; Trabattoni D; Andreini D; Ferrante G; Ancona M; Metra M; Curello S; Maffeo D; Pero G; Cacucci M; Assanelli E; Bellini B; Russo F; Ielasi A; Tespili M; Danzi GB; Vandoni P; Bollati M; Barbieri L; Oreglia J; Lettieri C; Cremonesi A; Carugo S; Reimers B; Condorelli G; Chieffo A Circulation; 2020 Jun; 141(25):2113-2116. PubMed ID: 32352306 [No Abstract] [Full Text] [Related]
6. ST-segment elevation myocardial infarction in post-COVID-19 patients: A case series. Wong SW; Fan BE; Huang W; Chia YW Ann Acad Med Singap; 2021 May; 50(5):425-430. PubMed ID: 34100519 [TBL] [Abstract][Full Text] [Related]
8. COVID-19-Specific Strategies for the Treatment of ST-Segment Elevation Myocardial Infarction in China. Ranard LS; Parikh SA; Kirtane AJ J Am Coll Cardiol; 2020 Sep; 76(11):1325-1327. PubMed ID: 32807587 [TBL] [Abstract][Full Text] [Related]
9. Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead". Verdoia M; De Luca G Atherosclerosis; 2021 Nov; 336():49-50. PubMed ID: 34635335 [No Abstract] [Full Text] [Related]
11. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Ueki Y; Otsuka T; Windecker S; Räber L Eur Heart J; 2020 Jun; 41(22):2134. PubMed ID: 32374405 [No Abstract] [Full Text] [Related]
12. Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual? Daniels MJ; Cohen MG; Bavry AA; Kumbhani DJ Circulation; 2020 Jun; 141(24):1948-1950. PubMed ID: 32282225 [No Abstract] [Full Text] [Related]
13. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy. Bainey KR; Bates ER; Armstrong PW Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006834. PubMed ID: 32339038 [No Abstract] [Full Text] [Related]
14. COVID-19 (SARS-CoV-2) and the Heart - An Ominous Association. Khalid N; Chen Y; Case BC; Shlofmitz E; Wermers JP; Rogers T; Ben-Dor I; Waksman R Cardiovasc Revasc Med; 2020 Aug; 21(8):946-949. PubMed ID: 32423791 [TBL] [Abstract][Full Text] [Related]
15. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of prehospital administration of unfractionated heparin, enoxaparin or bivalirudin in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Insights from the ORBI registry. Auffret V; Leurent G; Boulmier D; Bedossa M; Zabalawi A; Hacot JP; Coudert I; Filippi E; Castellant P; Rialan A; Rouault G; Druelles P; Boulanger B; Treuil J; Avez B; Le Guellec M; Gilard M; Le Breton H Arch Cardiovasc Dis; 2016 Dec; 109(12):696-707. PubMed ID: 27818120 [TBL] [Abstract][Full Text] [Related]
17. Management of ST elevation myocardial infarction (STEMI) with primary angioplasty in Covid 19 lockdown. Kumar M; Tyagi N; Arora M Indian Heart J; 2020; 72(4):325-326. PubMed ID: 32861396 [No Abstract] [Full Text] [Related]
18. Multiple spontaneous coronary thrombosis causing ST-elevation myocardial infarction in a patient with COVID-19. Kurdi H; Obaid DR; UlHaq Z; Ionescu A; Sekar B Br J Hosp Med (Lond); 2020 Jul; 81(7):1-6. PubMed ID: 32730159 [No Abstract] [Full Text] [Related]
19. The Unbearable Thrombus of COVID-19: Primary PCI, Thrombus, and COVID-19. Dauerman HL J Am Coll Cardiol; 2020 Sep; 76(10):1177-1180. PubMed ID: 32883410 [TBL] [Abstract][Full Text] [Related]
20. Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend. Kirtane AJ; Bangalore S Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006885. PubMed ID: 32339025 [No Abstract] [Full Text] [Related] [Next] [New Search]